N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open-Authors' reply

Lancet Respir Med. 2017 Jan;5(1):e3. doi: 10.1016/S2213-2600(16)30418-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acetylcysteine*
  • Administration, Inhalation
  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Pulmonary Fibrosis
  • Vital Capacity

Substances

  • Acetylcysteine